Dr. Daniela Bota's lab at UC Irvine focuses on understanding and alleviating the negative effects of chemotherapy on the nervous system, particularly for women with ovarian cancer. By targeting specific molecular pathways that lead to damage, the team aims to find ways to reduce cognitive decline and neuropathic pain that often accompany cisplatin treatment. Their research seeks to develop new treatments to improve patients' quality of life.

Dr. Steve A N Goldstein's lab at UC Irvine focuses on understanding how neutrophils, the white blood cells crucial for our immune response, contribute to lung injury during infections like COVID-19 and bacterial pneumonia. The lab investigates a specialized channel in these cells called hHv1, which plays a key role in driving inflammation. By developing inhibitors that target hHv1, the lab aims to find new treatments to prevent and mitigate acute lung injury and its severe form, ARDS.

Dr. Yilin Hu's lab at UC Irvine focuses on studying nitrogenase, an important enzyme that converts atmospheric nitrogen into ammonia, which is crucial for agriculture and the environment. The team investigates how nitrogenase operates at a molecular level and seeks to improve its expression in bacteria. Their work aims to find innovative applications for nitrogenase that could enhance crop yields and reduce pollution, ultimately contributing to sustainable agricultural practices.

Dr. Christopher C. W. Hughes leads a research lab that focuses on developing advanced models for studying a form of cancer known as peritoneal carcinomatosis, particularly as it relates to colorectal and gastric cancers. The lab aims to create a microfluidic system that closely mimics human tissues to better understand tumor behavior and discover new treatments. Ultimately, their efforts will contribute to improved therapies for patients suffering from these aggressive cancers, addressing significant health disparities related to treatment outcomes.

The lab led by Dr. Daniele Piomelli at UC Irvine focuses on pain management, particularly by targeting a specific enzyme called NAAA to develop new pain medications that do not carry the risk of addiction. The research primarily explores how inhibiting this enzyme could lead to effective treatments for people suffering from acute and chronic pain. By studying animal models, the lab aims to uncover the cellular mechanisms involved in pain processing and to improve drug candidates for safer pain relief.

Dr. Maksim V Plikus' lab focuses on understanding how hair follicles control their growth and size. Using a combination of advanced techniques, including mouse models and computational analysis, the lab studies the interactions between different cell types within hair follicles. Their research aims to reveal the complex signaling mechanisms that allow tissues to maintain their intended size, which has important implications for both basic biology and potential medical applications.

Dr. Geoffrey Abbott's lab at UC Irvine focuses on understanding how certain small molecules can influence potassium channels in the brain. These channels are important for neuron function and play a role in conditions like epilepsy and addiction. By studying compounds derived from plants, the team aims to develop new treatments for these serious health issues. Their research combines advanced simulations, mutagenesis techniques, and mouse model testing to discover how these compounds work and how they can help in therapy.

Dr. Jennifer Prescher's lab at UC Irvine focuses on groundbreaking technologies to visualize RNA in real time within living cells. By developing tiny RNA tags that can work with split luciferases, her team aims to tackle key questions about RNA dynamics, which are crucial for understanding various biological processes like memory and immune functions. Their innovative imaging methods will help track RNA behavior continuously and provide insights necessary for advancing health-related research.

Dr. Qin Yang's lab at the University of California-Irvine focuses on understanding how genetic factors contribute to type 2 diabetes, particularly through mechanisms like alternative polyadenylation. By studying specific genes and their regulation, the lab aims to uncover how these processes affect insulin production and function in pancreatic cells. This research not only elucidates basic biological mechanisms but also seeks to improve diabetes prevention strategies for individuals at genetic risk.

Dr. Gelareh Sadigh's lab focuses on reducing financial barriers for cancer patients through innovative support programs. They aim to improve patient experiences and outcomes by enhancing communication about treatment costs and providing guidance on financial assistance. The lab's projects involve direct counseling and education to help patients navigate their healthcare costs more effectively.

Dr. Seyed Ahmad Sajjadi's lab focuses on improving the diagnosis and understanding of two significant types of dementia that often affect older adults: limbic predominant age-related TDP-43 encephalopathy (LATE) and hippocampal sclerosis of aging (HS-A). By studying brain health in participants aged 85 and older, the lab aims to identify biomarkers and develop innovative methods to recruit diverse populations for clinical trials. The ultimate goal is to better understand and address cognitive decline in the aging population, paving the way for new treatments.

Dr. Thomas F Schilling's lab at UC Irvine investigates how cells organize themselves during the development of the skeleton, particularly focusing on craniofacial bones. They aim to understand the signals that guide cartilage growth and alignment, which is crucial for normal bone formation. Insights from this research could lead to better treatments for skeletal disorders and congenital malformations.

Dr. Mukherjee's lab at UC Irvine focuses on developing innovative imaging agents to help diagnose and understand Alzheimer's disease. The primary goal is to create novel tracers that can bind to Tau proteins, which are critical in understanding the progression of this neurodegenerative disease. By utilizing advanced imaging techniques like PET and SPECT, the lab aims to improve early detection and treatment strategies for Alzheimer's and related disorders.

Marcus Michael Seldin's lab at UC Irvine focuses on understanding how different organs communicate with each other, particularly in the context of diseases like obesity and type 2 diabetes. By combining computational tools with experimental research, the lab aims to identify and validate new endocrine signaling pathways. This innovative integration of bioinformatics and experimental techniques will help uncover the mechanisms of organ communication and their implications in metabolic diseases.

Dr. Arash Kheradvar's lab focuses on innovative heart valve tissue engineering and understanding the mechanics of heart function in diseases like pulmonary arterial hypertension. His research aims to develop living tissue valves that can better mimic native heart valves and to non-invasively monitor right ventricle function in patients with heart disease. They aim to improve patient outcomes by enhancing the performance and longevity of heart valves and utilizing advanced imaging techniques for clinical monitoring.

Dr. Thomas P. Burke's lab focuses on understanding how Rickettsia, a type of tick-borne bacteria, evade the immune system. They are investigating how these bacteria survive inside immune cells and how they avoid detection by the body's defenses. This research could lead to new treatments and vaccines for serious diseases caused by Rickettsia, such as Rocky Mountain spotted fever.

Dr. Ivan Marazzi's lab at UC Irvine focuses on understanding how inflammation affects disease responses during infections and in neurodegenerative conditions like ALS. Their current projects explore how the immune system, particularly certain T cells, influences the severity of COVID-19 and a rare juvenile form of motor neuron disease. The lab aims to develop therapeutic strategies based on their findings to better manage these diseases.

Dr. Shivashankar Othy's lab at UC Irvine focuses on understanding how specific immune cells, known as regulatory T cells, operate in the central nervous system during autoimmune diseases like multiple sclerosis. The research aims to uncover how these immune cells can help reduce inflammation and promote tissue repair. By employing advanced imaging techniques, the lab seeks to reveal new details about the interactions within the immune system that could lead to better treatments for autoimmune disorders.

Dr. Kevin T. Beier's research focuses on understanding how changes in the retrosplenial cortex, a specific brain region, contribute to the progression of Alzheimer's disease (AD). By studying both mouse models and human post-mortem samples, the lab aims to identify early indicators of AD and the molecular mechanisms involved. This research could lead to new therapeutic strategies to combat AD-related memory loss.

Dr. Candice Odgers' lab at UC Irvine focuses on understanding how social media use impacts mental health during early adolescence. By tracking a large group of young adolescents using innovative methods like ecological momentary assessment and wearable technologies, the research aims to uncover how changes in social media engagement can affect mental health symptoms like anxiety and depression. This research is critical as it seeks to inform parents, policymakers, and educators about the effects of social media on young people's well-being.